Chinese cryptocurrency asset managers hope to avoid an intensified crackdown at home by expanding in places such as Hong Kong and Singapore.
Cryptocurrency-focused hedge funds enjoyed hefty gains this year thanks to bitcoin’s recent surge to over $18,000, close to its 2017 high.
China has been tightening scrutiny over cryptocurrencies as the People’s Bank of China (PBOC) launches its digital currency, partly as a response to the threat from currencies like bitcoin.
Consequently, Chinese businessmen are looking elsewhere to raise crypto-focused funds.
Among them is Babel Finance, a cryptocurrency financial services provider founded by Chinese entrepreneur Flex Yang, which applied for an asset management license in Hong Kong.
According to Yang, a license in Hong Kong would help Babel become a “gateway” between traditional financial institutions and crypto investing.
Yang, who hopes to raise $1 billion upon receiving a license in Hong Kong, dreams of making Babel Finance the “JPMorgan in the field of cryptocurrency.”
Gordon Chen, an ex-bitcoin trader in Beijing who co-founded cryptocurrency asset manager GMR in Singapore last year, chose Singapore because of its regulatory structure.
Chen currently manages over $20 million of bitcoin assets.
China banned virtual currency trading in 2017, stunting an emerging crypto industry, and bringing down its share of global bitcoin trading to less than 4 percent, from nearly 17 percent.
Several of the world’s largest crypto trading platforms founded in China were forced to move overseas in 2017.
In October, the PBOC outlawed the private issuance of digital currencies, forcing Malta-based exchange OKEX to suspend cryptocurrency withdrawals for a month.
GMR’s Chen noted that China had lost its global pricing power and its role as a key hub for bitcoin trading and mining.


Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
SK Hynix Shares Surge on Record $28.6 Billion Buyback
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
Shein Targets $26B-$27B Valuation for Hong Kong IPO
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut 



